Patents by Inventor Barbara Krampitz

Barbara Krampitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising a combination of DHA and EPA for administration prior to commencement of chemotherapy
    Patent number: 9675574
    Abstract: The invention relates to a composition comprising a combination of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The composition can be used for enhancing the activity of chemotherapy or radiotherapy and/or in the prevention or reduction of side effects caused by the chemotherapy or radiotherapy in a patient ill with cancer, the composition being intended for administration to the patient prior to the commencement of a cycle of chemotherapy or radiotherapy.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: June 13, 2017
    Assignee: Fresenius Kabi Deutschland GmbH
    Inventors: Ewald Schlotzer, Barbara Krampitz, Ulrich Suchner
  • COMPOSITION COMPRISING A COMBINATION OF DHA AND EPA FOR ADMINISTRATION PRIOR TO COMMENCEMENT OF CHEMOTHERAPY
    Publication number: 20150297549
    Abstract: The invention relates to a composition comprising a combination of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The composition can be used for enhancing the activity of chemotherapy or radiotherapy and/or in the prevention or reduction of side effects caused by the chemotherapy or radiotherapy in a patient ill with cancer, the composition being intended for administration to the patient prior to the commencement of a cycle of chemotherapy or radiotherapy.
    Type: Application
    Filed: March 31, 2015
    Publication date: October 22, 2015
    Inventors: Ewald Schlotzer, Barbara Krampitz, Ulrich Suchner
  • COMPOSITION COMPRISING A COMBINATION OF DHA AND EPA FOR ADMINISTRATION PRIOR TO COMMENCEMENT OF CHEMOTHERAPY
    Publication number: 20130197087
    Abstract: The invention relates to a composition comprising a combination of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The composition can be used for enhancing the activity of chemotherapy or radiotherapy and/or in the prevention or reduction of side effects caused by the chemotherapy or radiotherapy in a patient ill with cancer, the composition being intended for administration to the patient prior to the commencement of a cycle of chemotherapy or radiotherapy.
    Type: Application
    Filed: August 26, 2011
    Publication date: August 1, 2013
    Applicant: Fresenius Kabi Deutschland GmbH
    Inventors: Ewald Schlotzer, Barbara Krampitz, Ulrich Suchner